|
Volumn 40, Issue 8, 2008, Pages 2631-2633
|
Tuberculosis After Heart Transplantation: Twenty Years of Experience in a Single Center in Taiwan
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CIPROFLOXACIN;
CYCLOSPORIN;
ETHAMBUTOL;
ISONIAZID;
LEVOFLOXACIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
PYRAZINAMIDE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
STREPTOMYCIN;
TACROLIMUS;
ADD ON THERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CULTURE MEDIUM;
DEMOGRAPHY;
DIAGNOSTIC PROCEDURE;
DRUG DOSE INCREASE;
DRUG SUBSTITUTION;
EXPERIENCE;
FEMALE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
INFECTION RATE;
LUNG LESION;
MALE;
MEDICAL RECORD REVIEW;
MORTALITY;
PHYSICAL DISEASE BY BODY FUNCTION;
PRIORITY JOURNAL;
TAIWAN;
TOXIC HEPATITIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
TUBERCULOSIS;
ADULT;
AGED;
ANTITUBERCULAR AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
TAIWAN;
TUBERCULOSIS, PULMONARY;
|
EID: 53149151059
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2008.08.013 Document Type: Article |
Times cited : (11)
|
References (9)
|